Boule Diagnostics AB (BOUL ST) stock market data APIs
kr3.327
0.1(3%)
as of May 18, 2026
Try our APIs with
free plan!
Boule Diagnostics AB Financial Data Overview
Price chart is built with
Anychart
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
Prev. Close
3.327
Open
3.4247
High
3.4758
Low
3.2206
52 wk Range
3.14-10.6
Market Cap
134 M
Shares Outstanding
38 833 K
Revenue
478 M
EPS
-0.17
Beta
0.166
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Boule Diagnostics AB data using free add-ons & libraries
Get Boule Diagnostics AB Fundamental Data
Boule Diagnostics AB Fundamental data includes:
- Net Revenue: 478 M
- EBITDA: 49 154 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-04-28
- EPS/Forecast: 0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Boule Diagnostics AB News
New
An Intrinsic Calculation For Boule Diagnostics AB (publ) (STO:BOUL) Suggests It's 23% Undervalued
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Boule Diagnostics AB (publ) (STO:BOUL) as an investment opportunity by taking the expected future cash ...
Did Business Growth Power Boule Diagnostics' (STO:BOUL) Share Price Gain of 135%?
While Boule Diagnostics AB (publ) (STO:BOUL) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 19% in the last quarter. But t...
Should You Be Concerned With Boule Diagnostics AB (publ)'s (STO:BOUL) -8.6% Earnings Drop?
Today I will examine Boule Diagnostics AB (publ)'s (OM:BOUL) latest earnings update (31 December 2019) and compare these figures against its performance over the past couple of years, in addition to h...
Get Boule Diagnostics AB fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
